Previous 10 | Next 10 |
home / stock / glaxf / glaxf news
Fisher’s 13F portfolio value increased from ~$133.5B to ~$142B in Q1 2021. They increased Walt Disney and Eli Lilly while trimming Taiwan Semi, JD.com, and Pinduoduo. Fisher has a number of small positions in several ETFs/ETNs. For further details see: Tracking Ke...
GlaxoSmithKline plc (GSK) Q1 2021 Earnings Conference Call April 28, 2021, 09:00 AM ET Company Participants Emma Walmsley - CEO Iain Mackay - CFO Luke Miels - President, Global Pharmaceuticals David Redfern - Chief Strategy Officer Brian McNamara - CEO, Consumer Healthcare Hal Barron - Chief ...
The following slide deck was published by GlaxoSmithKline plc in conjunction with their 2021 Q1 earnings call. For further details see: GlaxoSmithKline plc 2021 Q1 - Results - Earnings Call Presentation
Clovis Oncology is a highly volatile stock that rises and falls cyclically. Despite Rubraca's approval for two deadly cancer indications (ovarian and prostate), sales have been increasing modestly. Nevertheless, the latest ARIEL4 data positioned Rubraca to become the first-line dr...
GlaxoSmithKline is a British, international pharma company formed in early 2000, and was the world's sixth-largest pharma company as of 2019. It is the fourth largest stock on the London Stock Exchange, but holds the dubious honor of agreeing to pay the largest settlement by a drug co...
Healthcare is one of the most defensive sectors and often contains strong moats. Fortunately for income investors, there are also numerous high-yield opportunities in the space. We highlight four high-yield healthcare stocks that could richly reward investors. For further de...
GlaxoSmithKline plc (GSK) Barclays Global Healthcare Conference 2021 March 10, 2021 8:35 AM ET Company Participants Deborah Waterhouse - CEO, ViiV Healthcare, GlaxoSmithKline plc Conference Call Participants Emily Field - European Pharmaceuticals Analyst, Barclays Presentation Emily Field Sor...
GlaxoSmithKline plc (GSK) Cowen 41st Annual Health Care Conference March 01, 2021 12:20 PM ET Company Participants Dr. Hal Barron - Chief Scientific Officer, President of R&D Conference Call Participants Steve Scala - Cowen and Company Presentation Steve Scala Good afternoon, and welcome ...
There is growing demand for AI use in drug development. Drug development deals go from $5 million to over $1 billion. Predictive Oncology has a unique platform using real patient samples in its AI process. Predictive Oncology could be undervalued if it can ink large or multipl...
Protagenic Therapeutics has filed to raise $17.5 million in an IPO, although the final figure may differ. The company is developing a treatment candidate for PTSD, depression and anxiety conditions. PTIX is a tiny firm still at a preclinical stage, so is ultra-high risk. For...
News, Short Squeeze, Breakout and More Instantly...
New York City, NY:March 27, 2020 – Published via (Wired Release) – Recent Research and Future Market Potential of Color Ultrasonic Diagnostic Apparatus Market in Global Industry: 2020 Research and New Innovations in Medical Devices Sector. The prime objective of the report is to ...
New York City, NY:March 27, 2020 – Published via (Wired Release) – Recent Research and Future Market Potential of Chemical Mechanical Planarization Slurries Market in Global Industry: 2020 Research and New Innovations in Chemicals and Materials Sector. The prime objective of the ...